# A Danish Pragmatic Randomized Trial of Nutritional Supplements in Heart Failure

Study · id `cardio:ct-nct06694727` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06694727](<https://clinicaltrials.gov/study/NCT06694727>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06694727

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 4044 participants.

## Technical summary

Registry record NCT06694727. Randomized; quadruple masking; primary purpose treatment. Start 2025-09-30 (actual); primary completion 2028-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 4044 participants (planned count; ClinicalTrials.gov record NCT06694727, source copy `cardio:ctgov-nct06694727-2025-10-03`, retrieved 2026-10-26)
- Started: 2025-09-30 (actual) (ClinicalTrials.gov record NCT06694727, source copy `cardio:ctgov-nct06694727-2025-10-03`, retrieved 2026-10-26)
- Primary completion: 2028-12-01 (anticipated) (ClinicalTrials.gov record NCT06694727, source copy `cardio:ctgov-nct06694727-2025-10-03`, retrieved 2026-10-26)
- Completion: 2029-06-01 (anticipated) (ClinicalTrials.gov record NCT06694727, source copy `cardio:ctgov-nct06694727-2025-10-03`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT06694727, source copy `cardio:ctgov-nct06694727-2025-10-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06694727-2025-10-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Danish Pragmatic Randomized Trial of Nutritional Supplements in Heart Failure
- Acronym: DANUTRIO-HF
- Condition: Heart Failure
- Intervention (Dietary supplement): Coenzyme Q10 100 Milligrams Oral Capsule
- Intervention (Dietary supplement): Selenium 100 Micrograms Oral Tablets
- Lead sponsor: Tor Biering-Sørensen
- Lead sponsor class: OTHER
- Collaborator: Pharma Nord
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Tor Biering-Sørensen (`cardio:org-tor-biering-srensen-bf541f`)
- Registry lists this organization as a collaborator: Pharma Nord (`cardio:org-pharma-nord`)

## Provenance

Content hash: 31d1a9eacd832376c7ecf5c06f726e75dd62edac029b7ffef8cab14082ab2e3e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
